ENTITY
Keymed Biosciences

Keymed Biosciences (2162 HK)

104
Analysis
Health Care • China
Keymed Biosciences is a biotechnology company focused on the in-house discovery and development of innovative biological therapies for autoimmune diseases and oncology. Their pipeline includes over 50 programs, with key products like Kangyueda® (Stapokibart, CM310) for atopic dermatitis, chronic rhinosinusitis with nasal polyps, and seasonal allergic rhinitis. The company was founded in 2016 and is headquartered in Chengdu, China.
more
Company Event • 25 Mar 2027 17:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 19 Aug 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 26 Mar 2026 17:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 26 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

Company Event • 24 Mar 2025 17:00 • Upcoming
Add To Calendar

H2 2024

x